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Abstract  
Hoigne syndrome (HS) is the term coined to describe an acute, non-allergic, psychiatrically based reaction 
occurring with a wide list of medications, mainly antibiotics. Since its first description by Hoigne and Schoch in 
1959, few cases have been reported in medical literature and, although antimicrobials are commonly used, very 
rarely in dermatology. The authors describe the first case occurred after intralesional administration of meglumine 
antimoniate and briefly discuss the pathogenetic hypotheses on this atypical adverse drug reaction. 
Introduction 
 
Hoigne syndrome (HS) is the term coined to 
describe an acute, non-allergic, psychiatrically based 
reaction [1] occurring with a wide list of medications, 
mainly antibiotics (thus the other terms used as 
“pseudoanaphylactic reaction to procaine penicillin” 
[2], “acute psychotic syndrome after penicillin” [3] or 
“antibiomania [4]). 
Since its first description by Hoigne and 
Schoch [5] in 1959 few cases have been reported in 
medical literature and, although antimicrobials are 
commonly used, very rarely in dermatology. No 
reports of HS with the use of antiparasitic drugs have 
also been found.  
A 56-year-old woman sought attention 
because of an erythematous-infiltrative slowly 
progressing lesion of the medium dorsal third of the 
right forearm present for the last four months. At he 
beginning of the disease, the patient noticed a small 
red, itchy papule, which he treated as a mosquito bite 
using betamethasone/fusidic acid cream, with no 
significant improvement. A complete clinical 
evaluation showed the patient in good health, with a 
history of cutaneous superficial spreading melanoma 
seven years ago.  
A 3 mm punch-biopsy was performed for 
diagnostic assessment and histologically stained with 
haematoxylin and eosin. Microscopic examination 
revealed a granulomatous dermic infiltrate, consisting 
of lymphocytes, histiocytes and multinuclear giant 
cells, being coherent with the clinical suspect of 
cutaneous leishmaniasis. Touch imprint from the 
biopsy specimen and microscopic examination 
(Giemsa stain) confirmed the diagnosis through the 
evidence of Leishmania amastigotes. Therapeutic 
regimen with N-methylglucamine antimoniate, 1 ml 
twice a week was proposed and the drug 
administered intralesionally at our clinic. 
Immediately after the fourth injection of the 
drug, the patient presented confusion, disorganised 
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thinking, visual and auditory hallucinations. She also 
reported exaggerating anxiety and psychomotor 
agitation.  
We provided laboratory tests including thyroid 
levels and toxicology, electrocardiogram together with 
neurological and psychiatric evaluation, all resulting 
within normal limits. A computer tomography of the 
brain was also unremarkable. In the further two days, 
the patient referred sleep disturbances with underlying 
anxiety and fear.  
Antimonials were withdrawal, and a significant 
improvement of these symptoms was seen in the 
following days. The patient denied any previous 
similar manifestations to drugs as well as the personal 
and familial history of allergic/anaphylactic diseases in 
the past. He refused any further drug administration, 
including replacement with oral itraconazole, and the 
cutaneous disease remained unchanged. 
HS is a sort of acute pseudoallergic reaction 
having psychiatric symptoms, disturbances of 
perceptions and intense anxiety as main clinical 
features, occurring with the administration, especially 
infusion, of a series of drugs, varying from 
anaesthetics to intralesional steroids and oral 
antibiotics.  
Neurological signs and symptoms may 
present at a different degree, most cases including 
panic, fear of death, alteration of consciousness, 
hallucinations, accompanied by tachycardia, 
tachypnea, hypertension and numbness in the 
extremities [7].  
Usually, the withdrawal of the offending drug 
leads to the rapid attenuation of symptoms, with 
excellent prognosis [1,3,5]. As many different drugs, 
with different pharmacodynamics and ways of 
administration, have been reported to cause acute 
psychiatric reactions, the complete improvement of 
the condition occurs in minutes to days [4,7,8]. 
The exact mechanism by some drugs may 
induce these effects remains largely unexplained and 
more than 200 pharmacological agents have been 
claimed as causative.  
Local anaesthetics (lidocaine, procaine, 
cocaine) have been involved in the majority of case 
reports and suspected to be responsible for the 
development of limbic kindling through the facilitation 
of excitatory N-methyl-D-aspartate receptors [6,9] and 
a reduction in the inhibitory activity of gamma-
aminobutyric acid (GABA) transmission [6,10]. This 
theory, however, requires previous sensitization to the 
anaesthetic that is not met in all cases of HS 
described in the medical literature [11]. 
Alternatively, it was speculated that drug 
microcrystals injection might cause microembolization 
of small vessels of the brain and/or lungs [12]. In fact, 
an embolism is a well-known biological phenomenon 
representing a possible complication of a variety of 
conditions [13,14],  which can also involve any organ 
or apparatus with drug administration as well as it 
occurs locally with Nicolau syndrome [15] at the 
cutaneous level. Depending upon the size of these 
particles and their solubility in the blood, they can 
reach the diverse systems thus explaining such 
reactions [16]. Lastly, some authors postulated that 
the inhibition of the hepatic cytochrome P450 (CYP) 
isoenzymes, subclass CYP3A4, may play a role in the 
induction of neurological [17] and psychiatric [8] 
disorders. 
Mediterranian basin is an endemic region for 
several parasitoses [18, 19]. Among these, cutaneous 
leishmaniasis is relatively frequent, mostly due to 
Leishmania infantum , carried by the female sandflies 
of Phlebotomus perniciosus [20].  
Several drug therapies are effective in the 
treatment of cutaneous leishmaniasis [19] and 
antimonials have been widely used in localized forms 
[21]. In our experience intralesional meglumine 
antimoniate (Glucantime) is useful and manageable, 
through the selective inhibition of enzymes involved in 
parasite anaerobic metabolism, with rapid clinical 
response and little discomfort for the patient [22]. 
To the best of our knowledge this is the first 
report of HS in course of antiparasitic drugs.  
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